Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 30‑Month Interim Analysis of Post‑marketing Surveillance

Authors

Izumi Kawachi (ORCID: https://orcid.org/0000-0002-7140-8500)
Noriko Isobe (ORCID: https://orcid.org/0000-0001-9525-4254)
Yusei Miyazaki (ORCID: https://orcid.org/0000-0002-8235-7569)
Takashi Yamamura (ORCID: https://orcid.org/0000-0001-9048-0375)
Jin Nakahara (ORCID: https://orcid.org/0000-0002-5858-0998)
Ichiro Nakashima (ORCID: https://orcid.org/0000-0002-2612-8948)
Kazuo Fujihara (ORCID: https://orcid.org/0000-0002-3096-4156)
Katsuhisa Yamashita (ORCID: https://orcid.org/0000-0002-5761-1609)
Yuta Kamei (ORCID: https://orcid.org/0009-0006-3220-0084)
Minami Tomita
Chiyoko Nohara

Institutions

Fukushima Medical University (JP)
Kyushu University (JP)
Keio University (JP)
Ebara Hospital (JP)
National Hospital Organization Hokkaido Medical Center (JP)
National Center of Neurology and Psychiatry (JP)
Chugai Pharma (United States) (US)
Southern Tohoku General Hospital (JP)
Niigata University (JP)
Tohoku Medical and Pharmaceutical University (JP)

Publication Details

Journal: Neurology and Therapy
Published: 2025-09-25
DOI: https://doi.org/10.1007/s40120-025-00799-7
Citations: 2
Primary Topic: Multiple Sclerosis Research Studies
Type: article
Field-Weighted Citation Impact: 2.94

Funders

Chugai Pharmaceutical

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 30‑Month Interim Analysis of Post‑marketing Surveillance

Izumi Kawachi, Noriko Isobe, Yusei Miyazaki, Takashi Yamamura et al.

Sep 25, 2025

2 citations

Neurology and Therapy

Multiple Sclerosis Research Studies

2.94

article

Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 30‑Month Interim Analysis of Post‑marketing Surveillance

Izumi Kawachi, Noriko Isobe, Yusei Miyazaki, Takashi Yamamura, Jin Nakahara, Ichiro Nakashima, Kazuo Fujihara, Katsuhisa Yamashita, Yuta Kamei, Minami Tomita, Chiyoko Nohara

September 25, 2025article en

2 citations

Abstract

No abstract available for this paper.

Neurology and TherapyVol. 14(6)

Fukushima Medical University (JP), Kyushu University (JP), Keio University (JP), Ebara Hospital (JP), National Hospital Organization Hokkaido Medical Center (JP), National Center of Neurology and Psychiatry (JP), Chugai Pharma (United States) (US), Southern Tohoku General Hospital (JP), Niigata University (JP), Tohoku Medical and Pharmaceutical University (JP)

Chugai Pharmaceutical

Openalex Percentile: Top 8%

Multiple Sclerosis Research Studies

2.94

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.